Clinical Trials Results - National Cancer Institute


	Clinical Trials Search Results

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?

	NCI Highlights


	Virtual and Standard Colonoscopy Both Accurate Denosumab May Help Prevent Bone Loss Past Highlights



Results: 1 -10 of 30 Show results per page	View Search Criteria \| Help With Results

Last Modified: 6/1/2007 First Published: 2/1/2000


1.		Phase III Randomized Study of Fluorouracil and Leucovorin Calcium With or Without SU5416 in Patients With Metastatic Colorectal Cancer (Summary Last Modified 08/2001)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Closed				18 and over				Pharmaceutical / Industry				SUGEN-SU5416.031 UCLA-9909008, NCT00004252

Last Modified: 9/1/2001 First Published: 7/1/2001


2.		Phase III Randomized Study of Fluorouracil, Leucovorin Calcium, and Irinotecan With or Without SU5416 in Patients With Previously Untreated Metastatic Colorectal Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Closed				18 and over				NCI, Pharmaceutical / Industry				UCLA-001003701 SUGEN-SU5416.035, NCI-G01-1980, NCT00021281

Last Modified: 1/1/2000 First Published: 8/1/1999


3.		Phase I/II Study of SU5416 with Fluorouracil and Leucovorin Calcium in Patients with Metastatic Colorectal Cancer (Summary Last Modified 01/2000)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II, Phase I				Treatment				Closed				Over 18				NCI, Pharmaceutical / Industry				UCLA-9901075 SUGEN-SU5416.010, NCI-G99-1546

Last Modified: 3/26/2003 First Published: 3/1/2000


4.		Phase I/II Study of SU5416 in Patients With Recurrent High-Grade Astrocytoma or Mixed Glioma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II, Phase I				Treatment				Completed				18 and over				NCI				NABTC-9902 MSKCC-01045, NCI-00-C-0173, NABTC-99-02, NCT00004868

Last Modified: 5/1/2001 First Published: 7/1/2000


5.		Phase I/II Study of Daunorubicin Liposomal and SU5416 in Patients With Acute Myeloid Leukemia, Refractory Anemia With Excess Blasts (RAEB), RAEB in Transformation, or Chronic Myelomonocytic Leukemia Refractory to Induction Chemotherapy (Summary Last Modified 05/2001)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II, Phase I				Treatment				Completed				18 and over				NCI				MDA-ID-99341 NCI-673, NCT00005942, 673

Last Modified: 3/20/2003 First Published: 6/1/2000


6.		Phase I/II Study of SU5416 and Irinotecan in Patients With Advanced Colorectal Carcinoma (Summary Last Modified 04/2002)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II, Phase I				Treatment				Completed				18 and over				NCI				MDA-ID-99243 NCI-88, NCT00005818, 88

Last Modified: 8/2/2007 First Published: 9/1/2001


7.		Phase I/II Randomized Study of Neoadjuvant Radiotherapy With or Without SU5416 in Patients With Stage IB or IIA Soft Tissue Sarcoma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II, Phase I				Treatment				Completed				18 and over				NCI				RTOG-S-0120 NCT00023725

Last Modified: 8/2/2007 First Published: 9/1/2001


8.		Phase I/II Study of Neoadjuvant Chemotherapy Plus SU5416 and Radiotherapy Followed By Surgical Resection and Adjuvant Chemotherapy Plus SU5416 in Patients With High-Grade Stage IIC-III Soft Tissue Sarcoma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II, Phase I				Treatment				Completed				18 and over				NCI				RTOG-S-0121 NCT00023738

Last Modified: 2/1/2001 First Published: 4/1/2000


9.		Phase II Study of SU5416 in Patients With Cutaneous AIDS-Related Kaposi's Sarcoma (Summary Last Modified 02/2001)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Completed				18 and over				NCI				AMC-022 NCT00005042, AMC-022

Last Modified: 4/1/2002 First Published: 6/1/2000


10.		Phase II Study of SU5416 in Patients With Advanced, Metastatic, or Recurrent Soft Tissue Sarcoma or Gastrointestinal Stromal Tumor (Summary Last Modified 04/2002)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Completed				18 and over				NCI				DFCI-00002 NCI-330, NCT00005862, 330

Select All on One Page


					1 2 3 Next >

| | | | | | | |

A Service of the National Cancer Institute